Skip to main navigation Skip to search Skip to main content

Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice

  • A. Ben-Yehuda
  • , R. Bar-Tana
  • , A. Livoff
  • , N. Ron
  • , I. R. Cohen
  • , Y. Naparstek
  • Hadassah University Medical Centre

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Immunization with pathogenic lymphoid cells has been shown to induce resistance to disease in experimental animal models of cell mediated autoimmunity. In the present work we tested the effectiveness of this approach in a spontaneous murine autoimmune disease, the MRL/lpr/lpr (MRL/1) murine lupus model. We now report that the anti-DNA antibodies and glomerulonephritis of MRL/1 mice could be prevented by the adoptive transfer of spleen cells from MRL/+ mice that had been vaccinated with MRL/1 lymph node T lymphocytes, but not by direct vaccination of MRL/1 mice with their cells. These results indicate that the lupus of MRL/1 mice is susceptible to regulation by adoptive vaccination and that these autoimmune mice lack the ability to raise a suppressive response against their own pathogenic cells.

Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalLupus
Volume5
Issue number3
DOIs
StatePublished - Jun 1996
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Lupus
  • MRL-lpr/lpr
  • T cells
  • Vaccination

Fingerprint

Dive into the research topics of 'Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice'. Together they form a unique fingerprint.

Cite this